Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 3, 2012, Pages 237-243

  Codoner Franch P ^a,b   Tavarez Alonso S ^b   Murria Estal, R ^a   Tortajada Girbes M ^a   Simo Jorda R ^a   Alonso Iglesias, E ^b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Advanced oxidation protein products; Childhood obesity; Insulin resistance; Metabolic risk factors; Oxidative stress

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; BIOLOGICAL MARKER; DRUG DERIVATIVE; LIPID; MALONALDEHYDE; PROSTAGLANDIN F2 ALPHA; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL DERIVATIVE;

ADOLESCENT; ARTICLE; BLOOD; CHI SQUARE DISTRIBUTION; CHILD; DYSLIPIDEMIA; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; METABOLISM; OBESITY; ONSET AGE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SPAIN; SPECTROPHOTOMETRY; STATISTICAL MODEL; UPREGULATION;

ADOLESCENT; AGE OF ONSET; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHILD; DINOPROST; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LINEAR MODELS; LIPID PEROXIDATION; LIPIDS; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; SPECTROPHOTOMETRY; SULFHYDRYL COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UP-REGULATION;

EID: 84857910430     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.06.002     Document Type: Article

References (30)

1. Codoner-Franch P., Boix-García L., Simó-Jordá R., Del Castillo-Villaescusa C., Maset-Maldonado J., Valls-Bellés V. Is obesity associated with oxidative stress in children?. Int J Pediatr Obes 2010, 5:56-63. 10.1080/17477160903055945.
2. Hopps E., Noto D., Caimi G., Averna M.R. A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 2009, 20:72-77. 10.1016/j.numecd.2009.06.002.
3. Liu S.X., Hou F.F., Guo Z.J., Nagai R., Zhang W.R., Liu Z.Q., et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006, 26:1156-1162. 10.1161/01.ATV.0000214960.85469.68.
4. Krzystek-Korpacka M., Salmonowicz B., Boehm D., Berdowska I., Zielinski B., Patryn E., et al. Diagnostic potential of oxidative stress markers in children and adolescents with type 1 diabetes. Clin Biochem 2008, 41:48-55. 10.1016/j.clinbiochem.2007.10.003.
5. Pandey K.B., Mishra N., Rizvi S.I. Protein oxidation biomarkers in plasma of type 2 diabetic patients. Clin Biochem 2009, 43:508-511. 10.1016/j.clinbiochem.2009.11.011.
6. Atabek M.E., Keskin M., Yazici C., Kendirci M., Hatipoglu N., Koklu E., et al. Protein oxidation in obesity and insulin resistance. Eur J Pediatr 2006, 165:753-756. 10.1007/s00431-006-0165-5.
7. Krzystek-Korpacka M., Patryn E., Boehm D., Berdowska I., Zielinski B., Noczynska A. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Clin Biochem 2008, 41:943-949. 10.1016/j.clinbiochem.2008.04.024.
8. Sebeková K., Somoza V., Jarcusková M., Heidland A., Podracká L. Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int J Pediatr Obes 2009, 4:112-118. 10.1080/17477160802248039.
9. Anderstam B., Ann-Christin B.-H., Valli A., Stenvinkel P., Lindholm B., Suliman M.E. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clin Chim Acta 2008, 393:114-118. 10.1016/j.cca.2008.03.029.
10. Carrascosa Lezcano A., Fernández García J.M., Fernández Ramos C., Ferrández Longás A., López-Siguero J.P., Sánchez González E., et al. Spanish cross-sectional growth study 2008. Part II. Height, weight and body mass index values from birth to adulthood. An Pediatr (Barc) 2008, 68:552-569.
11. McCarthy H.D., Cole T.J., Fry T., Jebb S.A., Prentice A.M. Body fat reference curves for children. Int J Obes (Lond) 2006, 30:598-602. 10.1038/sj.ijo.0803232.
12. Fernández J.R., Redden D.T., Pietrobelli A., Allison D.B. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004, 145:439-444. 10.1016/j.peds.2004.06.044.
13. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114:555-576. National high blood pressure education program working group on high blood pressure in children and adolescent. 10.1542/peds.114.2.S2.555.
14. Matteucci E., Biasci E., Giampietro O. Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics. Acta Diabetol 2001, 38:187-189. 10.1007/s592-001-8077-3.
15. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304-1313. 10.1038/ki.1996.186.
16. Wong S.H., Knight J.A., Hopfer S.M., Zaharia O., Leach C.N., Sunderman F.W. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987, 33:214-220.
17. Santos M.T., Valles J., Aznar J., Vilches J. Determination of plasma malondialdehyde-like material and its clinical application in stroke patients. J Clin Pathol 1980, 33:973-976. 10.1136/jcp.33.10.973.
18. Alonso E., Cervera J., García-Espana A., Bendala E., Rubio V. Oxidative inactivation of carbamoyl phosphate synthetase (ammonia). Mechanism and sites of oxidation, degradation of the oxidized enzyme, and inactivation by glycerol, EDTA, and thiol protecting agents. J Biol Chem 1992, 267:4524-4532.
19. Zimmet P., Alberti K.G., Kaufman F., Tajima N., Silink M., Arslanian S., et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007, 8:299-306. 10.1111/j.1399-5448.2007.00271.x.
20. Keskin M., Kurtoglu S., Kendirci M., Atabek M.E., Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005, 115:e500-e503. 10.1542/peds.2004-1921.
21. Giannini C., de Giorgis T., Scarinci A., Ciampani M., Marcovecchio M.L., Chiarelli F., et al. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis 2008, 197:448-456. 10.1016/j.atherosclerosis.2007.06.023.
22. Valli A., Suliman M.E., Meert N., Vanholder R., Lindholm B., Stenvinkel P., et al. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Clin Chim Acta 2007, 379:87-94. 10.1016/j.cca.2006.12.026.
23. Franks P.W., Hanson R.L., Knowler W.C., Sievers M.L., Bennett P.H., Looker H.C. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010, 362:485-493.
24. Clapp B.R., Hingorani A.D., Kharbanda R.K., Mohamed-Ali V., Stephens J.W., Vallance P., et al. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 2004, 64:172-178. 10.1016/j.cardiores.2004.06.020.
25. Meaney E., Vela A., Samaniego V., Meaney A., Asbun J., Zempoalteca J.C., et al. Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the Mefisto Study. Clin Exp Pharmacol Physiol 2008, 35:895-903. 10.1111/j.1440-1681.2008.04920.x.
26. Woods A.A., Linton S.M., Davies M.J. Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem J 2003, 370:729-735. 10.1042/BJ20021710.
27. Piwowar A., Knapik-Kordecka M., Warwas M. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract 2007, 77:188-192. 10.1016/j.diabres.2006.12.007.
28. Goodman E., Daniels S.R., Meigs J.B., Dolan L.M. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007, 115:2316-2322. 10.1161/CIRCULATIONAHA.106.669994.
29. Marsche G., Frank S., Hrzenjak A., Holzer M., Dirnberger S., Wadsack C., et al. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res 2009, 104:750-757. 10.1161/CIRCRESAHA.108.193169.
30. Sebeková K., Boor P., Valachovicová M., Blazícek P., Parrák V., Babinská K., et al. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. Mol Nutr Food Res 2006, 50:858-868. 10.1002/mnfr.200500170.